The clinical information you need, at your fingertips.

Researchers found that a dimensional, symptom-based framework was better at predicting recovery and severity across common mental health outcomes compared with DSM diagnoses. . .

Veppanu (vepdegestrant) offers a new option for ER+/HER2-, ESR1-mutated advanced or metastatic breast cancer, where treatment resistance remains a major clinical challenge. . .

Large Cochrane review finds only modest benefits for preventing ARI-related visits in children under five. . .

A new expert review highlights how prevention and smarter risk stratification could reshape liver cancer screening. . .

Access to neurology care varies widely, but delays appear to be shaped more by how patients are prioritized than by how many neurologists are available. . .

U.S. prices for ultra-expensive, specialty drugs in Medicare Part D ran roughly four times higher than in comparable countries. But many of these drugs aren't sold abroad at all, limiting what reference-based pricing reforms can achieve. . .

A battery-powered molecular assay delivers rapid, accurate TB detection from sputum or tongue samples at the point of care. . .

A repurposed PDE4 inhibitor may modestly improve post-stroke memory without added safety concerns. . .

Glucagon-like peptide-1 receptor agonists reduced major cardiovascular events and mortality compared with placebo, with results holding in patients without diabetes. . .